Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction

Acute dystonic reactions are becoming much less prevalent in clinical practice due to the use of newer antipsychotics. Drug-drug interactions, patient characteristics, and environmental and genetic factors all contribute to the rate of occurrence of acute dystonia with second generation agents. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Sean, Cooke, Brian K., Nguyen, Mathew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670573/
https://www.ncbi.nlm.nih.gov/pubmed/23762720
http://dx.doi.org/10.1155/2013/136194
_version_ 1782271874552561664
author Paul, Sean
Cooke, Brian K.
Nguyen, Mathew
author_facet Paul, Sean
Cooke, Brian K.
Nguyen, Mathew
author_sort Paul, Sean
collection PubMed
description Acute dystonic reactions are becoming much less prevalent in clinical practice due to the use of newer antipsychotics. Drug-drug interactions, patient characteristics, and environmental and genetic factors all contribute to the rate of occurrence of acute dystonia with second generation agents. In this case, we report a glossopharyngeal dystonia secondary to a lurasidone-fluoxetine CYP-3A4 interaction to highlight the importance of maintaining an index of suspicion for laryngeal dystonia, a potentially fatal dystonia.
format Online
Article
Text
id pubmed-3670573
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36705732013-06-12 Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction Paul, Sean Cooke, Brian K. Nguyen, Mathew Case Rep Psychiatry Case Report Acute dystonic reactions are becoming much less prevalent in clinical practice due to the use of newer antipsychotics. Drug-drug interactions, patient characteristics, and environmental and genetic factors all contribute to the rate of occurrence of acute dystonia with second generation agents. In this case, we report a glossopharyngeal dystonia secondary to a lurasidone-fluoxetine CYP-3A4 interaction to highlight the importance of maintaining an index of suspicion for laryngeal dystonia, a potentially fatal dystonia. Hindawi Publishing Corporation 2013 2013-05-16 /pmc/articles/PMC3670573/ /pubmed/23762720 http://dx.doi.org/10.1155/2013/136194 Text en Copyright © 2013 Sean Paul et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Paul, Sean
Cooke, Brian K.
Nguyen, Mathew
Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction
title Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction
title_full Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction
title_fullStr Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction
title_full_unstemmed Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction
title_short Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction
title_sort glossopharyngeal dystonia secondary to a lurasidone-fluoxetine cyp-3a4 interaction
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670573/
https://www.ncbi.nlm.nih.gov/pubmed/23762720
http://dx.doi.org/10.1155/2013/136194
work_keys_str_mv AT paulsean glossopharyngealdystoniasecondarytoalurasidonefluoxetinecyp3a4interaction
AT cookebriank glossopharyngealdystoniasecondarytoalurasidonefluoxetinecyp3a4interaction
AT nguyenmathew glossopharyngealdystoniasecondarytoalurasidonefluoxetinecyp3a4interaction

Ejemplares similares